Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K1 | Q92918 | 6/20 | 0.44 |
| ▸ | MAP4K3 | Q8IVH8 | 1/20 | 0.44 |
| ▸ | SYK | P43405 | 7/20 | 0.37 |
| ▸ | JUN | P05412 | 2/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.36 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.36 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 2/20 | 0.36 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.36 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.36 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.36 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.36 |
| ▸ | TTK | P33981 | 1/20 | 0.36 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.35 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1570584 | 0.93 | MAP4K1 (0.44) | MAP4K1MAP4K3SYKKDRFGFR1 | |
| SCHEMBL13336145 | 0.92 | GRM2 (0.45) | MAP4K1MAP4K3SYKKDRFGFR3 | |
| SCHEMBL1570714 | 0.90 | WNT1 (0.41) | MAP4K1MAP4K3JUNMAPK8MAPK10 | |
| SCHEMBL13336028 | 0.88 | MAP4K1 (0.43) | MAP4K1MAP4K3SYKJUNMAPK8 | |
| SCHEMBL13336180 | 0.87 | MAP4K1 (0.44) | MAP4K1MAP4K3JUNMAPK8MAPK10 | |
| SCHEMBL1571320 | 0.86 | MAP4K1 (0.44) | MAP4K1MAP4K3JUNMAPK8MAPK10 | |
| SCHEMBL13336142 | 0.86 | TTK (0.44) | MAP4K1MAP4K3JUNMAPK8MAPK10 | |
| SCHEMBL13362991 | 0.85 | MAP4K1 (0.45) | MAP4K1MAP4K3JUNMAPK8MAPK10 | |
| SCHEMBL13336174 | 0.85 | GRM2 (0.45) | MAP4K1MAP4K3SYKJUNMAPK8 | |
| SCHEMBL13336192 | 0.85 | MAP4K1 (0.43) | MAP4K1MAP4K3SYKJUNMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100121052-A1 | Novel compounds for treating proliferative diseases | JAIN RAMA | 2010-05-13 | — | — | US | disclosed |
| US-20100121052-A1 | Novel compounds for treating proliferative diseases | JAIN RAMA | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121052-A1 | Novel compounds for treating proliferative diseases | PDK1, PDK2, PDK3 | MAP4K1 112/4885MAP4K3 103/4885SYK 4070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.